Antidepressant-associated sexual dysfunction study
A randomized, double-blind, active controlled clinical trial of switching to Vilazodone for antidepressant-associated sexual dysfunction.
Psychiatry and Neurobehavioral Sciences
Clayton Anita, H
You may qualify for a 3-month clinical research study to evaluate the effects on sexual functioning by switching to one of two FDA-approved antidepressants. You must be • 18 to 65 years old. • Currently taking an antidepressant, and your depression is well controlled. • Experiencing sexual side effects thought to be caused by your antidepressant medication. This study has 10 clinic visits and 1 blood draw. Compensation of up to $575.00 for all completed study visits. For more information please contact: Dea Papajorgji-Taylor, 434-243-4631, dp3fc@Virginia.edu Principal Investigator: Dr. Anita H. Clayton Center for Psychiatric Clinical Research IRB #16482
Center for Psychiatric Clinical Research
Compensation of up to $575.00 for all completed study visits.